Pharmacology

Beixin (Julie) He

Mentor: Mark E. Anderson, MD, PhD

Year Entered Into Program: 2007-2011

PhD Institution: Resident, Department of Internal Medicine, Magaw Medical Center, Northwestern University

Affiliations

  • Molecular Physiology and Biophysics Graduate Program

Research Description

The Role of Calcium/calmodulin-dependent Protein Kinase II (CaMKII) and Cellular Redox Balance in Hypertrophic Cardiomyopathy

Publication(s)

1.   Sander, T.L., Noll, L., Klinkner, D.B., Weihrauch, D., He, B.J., Kaul, S., Zangwill, S.D., Tweddell, J.S., Pritchard, K.A. Jr., Oldham, K.T.:  Rosiglitazone antagonizes vascular endothelial growth factor signaling and nuclear factor of activated T cells activation in cardiac valve endothelium. Endothelium, 13(3):181-190, 2006.  PMID: 16840174  http://www.ncbi.nlm.nih.gov/pubmed/16840174  2.   He, B.J., Joiner, M.A., Singh, M.V., Dominic-Swaminathan, P., Kutschke, W., Yang, J., Guan, X., Zimmerman, K., Grumbach, I.M., Weiss, R.M., Grumbach, D.R., Weiss, M., Spitz, R., Sigmund, C.D., Mohler, P.J., Anderson, M.E.:  Oxidation of CaMKII determines cardiotoxic effects of aldosterone. [in revision].  

Award(s)

  • NIH T32 Pharmacological Sciences Training Grant, 2007-2009
  • Recipient, Kirschstein NRSA Individual Predoctoral Fellowship, 2009-2012
  • Endocrine Society Travel Award, 2009